Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanye Tablets for type 2 diabetes mellitus with hyperlipidemia
ChiCTR-OPC-15006702Phase 2Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jun 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of Sanye Tongzhiqing Tablets in type 2 diabetes mellitus (T2DM) and hyperlipidemia (3 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: HbA1c. Planned start Jun 2015; status: not yet recruiting.
02
Drugs
Sanye Tongzhiqing Tablets
03
Conditions
type 2 diabetes mellitus (T2DM)hyperlipidemia
Beyond the preview
Go deeper on ChiCTR-OPC-15006702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006702.